InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: the gipper post# 5085

Wednesday, 08/15/2018 4:18:20 PM

Wednesday, August 15, 2018 4:18:20 PM

Post# of 6939
Totally agree. Extremely undervalued here especially now that they have fast track designation from the FDA for the NIBC indications. That is just the first on deck for the technology. If that one is approved it will open the flood gates to be expanded into many other indications. I urge a read of the 8-14-18 Seeking Alpha article regarding Verastem another clinical cancer babybio. Those metrics apply to SESN as well. Kudos to the poster on the VSTM iHub board for finding that article.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SESN News